Abstract
Due to the various side effects of conventional cancer treatment therapy, efforts to find anticancer agents with minimal side effects are in great demand. One of them is the synthesis of organotin(IV) hydroxybenzoate derivatives. Three organotin(IV) compounds, namely diphenyltin(IV) 2-hydroxybenzoate, [Ph2Sn(2-HBz)2] (DPT2-DH) (2), diphenyltin(IV) 3-hydroxybenzoate, [Ph2Sn(3-HBz)2] (DPT3-DH) (3) and diphenyltin(IV) 4-hydroxybenzoate, [Ph2Sn(4-HBz)2] (DPT4-DH) (4), have been successfully synthesized. Compounds 2–4 were obtained by reacting diphenyltin(IV) oxide, [Ph2SnO] (DPTO) (1) with 2-hydroxybenzoic acid (2-HHBz), 3-hydroxybenzoic acid (3-HHBz) and 4-hydroxybenzoic acid (4-HHBz), respectively. The compounds synthesized were fully characterized by UV–Vis, FT-IR, and NMR spectroscopies and microelemental analysis to see the purity of the compounds. The antiproliferative activity of the compounds was tested against three cancer cell lines of lung cancer (A549), breast cancer (MCF-7) and cervical cancer (HeLa), and their activities were compared to normal cell cancer, Vero. The results of the antiproliferative test demonstrated that compound 2 was found to be most active against the A549 cell line. Compounds 2 and 3 are active against MCF-7 while compound 4 was found to be least active against all cancer lines tested. All compounds have also been found to have a good selectivity index (SI) toward the A549 cell line, although their SI values are not good enough against the HeLa cell line.
Similar content being viewed by others
Data Availability
No datasets were generated or analysed during the current study.
References
M. McCall, M. McDonald, S. Thorne, A. Ward, C. Heneghan, Yoga for health-related quality of life in adult cancer: a randomized controlled feasibility study. Evid.-Based Compl. Altern. Med. (2015). https://doi.org/10.1155/2015/816820
H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer Statistics 2020, GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021). https://doi.org/10.3322/caac.21660
Cancer Observatory, Cancer Today, (2021). Accessed on December 25, 2023. https://gco.iarc.fr/Global
World Health Organization (WHO), Global Health Estimates, 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2019. WHO; 2020. Accessed on January 15, 2023. https://www.who.int/data/gho/data/theme%20s/morta%20lity-andgloba%20l-healt%20h-estim%20ates/ghe-leadingcauses-of-death
A. Annissa, T. Suhartati, Y. Yandri, S. Hadi, Antibacterial activity of Diphenyltin(IV) and triphenyltin(IV) 3-Chlorobenzoate against Pseudomonas aeruginosa and Bacillus subtilis. Orient. J. Chem. 33, 1133–1139 (2017). https://doi.org/10.13005/ojc/330310
M.R. Roner, C.E. Jr Carraher, K. Shahi, K. Barot, Antiviral activity of metal-containing polymers-Organotin and Cisplatin-Like Polymers materials. Mater. (Basel). 4, 91–112 (2011). https://doi.org/10.3390/ma4060991
C.S. Rocha, B.P. de Morais, B.L. Rodrigues, C.L. Donnici, G.M. de Lima, J.D. Ardisson, J.A. Takahashi, R.S. Bitzer, Spectroscopic and X-ray structural characterization of New Organotin carboxylates and their in Vitro Antifungal activities. Polyhedron. 117, 35–47 (2016). https://doi.org/10.1016/j.poly.2016.05.031
S. Samsuar, W. Simanjuntak, H.I. Qudus, Y. Yandri, H. Herasari, S. Hadi, In Vitro Antimicrobial Activity Study of some Organotin(IV) Chlorobenzoates against Staphylococcus aureus and Escherichia coli. J. Adv. Pharm. Edu Res. 11(2), 17–22 (2021). https://doi.org/10.51847/kaijZKAFCO
M. Sirajuddin, S. Ali, M.N. Tahir, Organotin(IV) derivatives based on 2-((2-methoxyphenyl) carbamoyl) Benzoic Acid: synthesis, Spectroscopic characterization, Assessment of Antibacterial, DNA Interaction, Anticancer and Antileishmanial potentials. J. Mol. Struct. 1229, 129600 (2021). https://doi.org/10.1016/j.molstruc.2020.129600
C.E. Jr Carraher, M.R. Roner, Organotin polymers as anticancer and antiviral agents. J. Organomet. Chem. 751, 67–82 (2014). https://doi.org/10.1016/j.jorganchem.2013.05.033
L. Pellerito, L. Nagy, Organotin(IV)n+ complexes formed with biologically active ligands: equilibrium and structural studies, and some biological aspects. Coord. Chem. Rev. 224, 111–150 (2002). https://doi.org/10.1016/S0010-8545(01)00399-X
S. Hadi, M.D. Fenska, N. Noviany, H. Satria, W. Simanjuntak, M.M. Naseer, Synthesis and antimalarial activity of some triphenyltin(IV) aminobenzoate compounds against Plasmodium Falciparum. Main Met. Group. Chem. 44, 256–260 (2021). https://doi.org/10.1515/mgmc-2021-0028
S. Hadi, T. Suhartati, N. Noviany, K.D. Pandiangan, Y. Yandri, W. Simanjuntak, Disinfecting activity of some diphenyltin(IV) benzoate derivative compounds. Pure Appl. Chem. 94, 799–807 (2022). https://doi.org/10.1515/pac-2021-1106
J.O. Adeyemi, D.C. Onwudiwe, A.C. Ekennia, R.C. Uwaoma, E.C. Hosten, Synthesis, characterization and antimicrobial studies of organotin(IV) complexes of N-methyl-N-phenyldithiocarbamate. Inorg. Chim. Acta. 477, 148–159 (2018). https://doi.org/10.1016/j.ica.2018.02.034
D.K. Kovala-Demertzi, V. Dokorou, Z. Ciunik, N. Kourkoumelis, M.A. Demertzis, Organotin mefenamic complexes preparations, spectroscopic studies and crystal structure of a triphenyltin ester of mefenamic acid: Novelanti-Tuberculosis agents. Appl. Organomet. Chem. 16, 360–368 (2002). https://doi.org/10.1002/aoc.308
S. Hadi, B. Irawan, T. Yandri, Suhartati, Synthesis, characterization and the antifungal activity test of some organotin(IV) benzoates. J. Phys. : Conf. Ser. 1751, 012099 (2021). https://doi.org/10.1088/1742-6596/1751/1/012099
C. Hansch, R.P. Verma, Larvicidal activities of some Organotin compounds on Mosquito Larvae: a QSAR Study. Eur. J. Med. Chem. 44, 260–273 (2009). https://doi.org/10.1016/j.ejmech.2008.02.040
S. Hadi, M. Noviany, Rilyanti, In Vitro Antimalarial activity of some Organotin(IV)2-Nitrobenzoate compounds against Plasmodium Falciparum. Maced J. Chem. Chem. Eng. 37, 185–191 (2018). https://doi.org/10.20450/mjcce.2018.1414
V.Y. Tyurin, W. Yaouhan, A.A. Prishchenko, D.B. Shpakovsky, Y.A. Gracheva, T.A. Antonenko, V.A. Tafeenko, D.V. Al´bov, L.A. Aslanov, E.R. Milaeva, Complexes of Organotin compounds with bis- and trisphosphonate derivatives of 2,6-ditertbutylphenol having antioxidant activity. Russ Chem. Bull. 64, 1419–1429 (2015). https://doi.org/10.1007/s11172-015-1026-z
R.R. Arraq, A.G. Hadi, Synthesis, identification, and anti-oxidant activity of Di-Organotin (IV)-Cephalexin complexes. J. Med. Chem. Sci. 6, 392–401 (2023). https://doi.org/10.26655/JMCHEMSCI.2023.2.19
S. Ramzan, S. Rahim, S.T. Hussain, K.B. Holt, J.K. Cockcroft, N. Muhammad, Z. Ur-Rehman, A. Nawaz, S. Shujah, Synthesis, characterization, X-ray structure, DNA binding, antioxidant and docking study of new organotin(IV) complexes. Appl. Organomet. Chem. 37, e7161 (2023). https://doi.org/10.1002/aoc.7161
W. Sari, H.I. Qudus, S. Hadi, The chemical reactivity study of organotin(IV) 4-aminobenzoates using cyclic voltammetry and antioxidant activity test by the DPPH method. Rev. Chim. 71(10), 28–37 (2020). https://doi.org/10.37358/RC.20.10.8347
M. Gielen, An overview of forty years Organotin Chemistry developed at the Free Universities of Brussels ULB and VUB. J. Braz Chem. Soc. 14, 870–877 (2003). https://doi.org/10.1590/S0103-50532003000600003
S. Hadi, M. Rilyanti, Synthesis and in vitro anticancer activity of some organotin(IV) benzoate compounds. Orient. J. Chem. 26, 775–779 (2010)
S. Hadi, M. Rilyanti, Suharso, in vitro activity and comparative studies of some organotin (iv) benzoate derivatives against leukemia cancer cell, L-1210. Indo J. Chem. 12, 172–177 (2012). https://doi.org/10.22146/ijc.21359
N. Uddin, F. Rashid, A. Haider, S.A. Tirmizi, A. Raheel, M. Imran, S. Zaib, P.L. Diaconescu, J. Iqbal, S. Ali, Triorganotin(IV) carboxylates as potential anticancer agents: their synthesis, physiochemical characterization, and cytotoxic activity against HeLa and MCF-7 Cancer Cells. Appl. Organomet. Chem. (2021). https://doi.org/10.1002/aoc.6165
S. Hadi, E.K. Winarno, H. Winarno, K.N. Berawi, T. Suhartati, N. Noviany, W. Simanjuntak, Y. Yandri, Synthesis and in vitro activity investigation of some dibutyl-, diphenyl-and triphenyltin (IV) carboxylates against leukemia cancer cell, L-1210. Pure Appl. Chem. 95, 823–832 (2023). https://doi.org/10.1515/pac-2023-0107
S. Hadi, E.K. Winarno, H. Winarno, K.N. Berawi, T. Suhartati, Y. Yandri, W. Simanjuntak, Synthesis, characterization and in vitro activity study of some organotin(IV) carboxylates against leukemia cancer cell, L-1210. Sustain. Chem. Res. : Chem. Biochem. Aspects (2023). https://doi.org/10.1515/9783111071435-008
S. Ramasamy, N. Abdul Wahab, N. Zainal Abidin, S. Manickam, Z. Zakaria, Growth inhibition of human gynecologic and Colon cancer cells by Phyllanthus watsonii through apoptosis induction. PLoS ONE. 7, e34793 (2012). https://doi.org/10.1371/journal.pone.0034793D
A. Szorcsik, L. Nagy, K. Gadja-Schrantz, L. Pellerito, E. Nagy, E.T. Edelmann, Structural studies on organotin(IV) complexes formed with ligands containing {S, N, O} donor atoms. J. Radioanal Nucl. Chem. 252, 523–530 (2002). https://doi.org/10.1023/A:1015802820423
E.K. Winarno, H. Winarno, Susanto, Antiproliferative activity of extracts and fractions from irradiated Curcuma zanthorrhiza rhizomes against mouse leukemia and human cancer cell lines. Atom Indo. 45, 159–164 (2009). https://doi.org/10.17146/aij.2019.957
R.A. Turner, Screening Methods in Pharmacology (Academic, New York, 1972), p. 255
Dachriyanus (2004) Spectroscopic Analysis of the Structure of Organic Compounds. LPTIK, Universitas Andalas, Padang, Indonesia, p.132.
M. López-Lázaro, A simple and reliable approach for assessing anticancer activity in vitro. Curr. Med. Chem. 22, 1324–1334 (2015). https://doi.org/10.2174/0929867322666150209150639
M.K. Amir, S. Khan, Z. Rehman, A. Shah, I.S. Butlerc, Anticancer activity of organotin(IV) carboxylates. Inorg. Chim. Acta. 423, 14–25 (2014). https://doi.org/10.1016/j.ica.2014.07.053
Z.A. Siddiqi, M. Shahid, S. Kumar, M. Khalid, S. Noor, Synthesis, crystal structure and in vitro antitumor activity of carboxylate bridged dinuclear organotin(IV) complexes. J. Organomet. Chem. 694, 3768–3774 (2009). https://doi.org/10.1016/j.jorganchem.2009.07.030
N. Awang, N.F. Kamaludin, I. Baba, K.M. Chan, N.F. Rajab, A. Hamid, Synthesis, characterization and Antitumor Activity of New Organotin(IV) Methoxyethyldithiocarbamate Complexes. Orient. J. Chem. 32, 101–107 (2016). https://doi.org/10.13005/ojc/320110
A. Mohammed, R. Makia, M. Ali, R. Raheem, E. Yousif, Cytotoxic effects of Valsartan Organotin(IV) complexes on human Lung Cancer cells. Biointer Res. Appl. Chem. 11, 8156–8164 (2021). https://doi.org/10.33263/BRIAC111.81568164
J.C. Pritchetta, L. Naesens, J. Montoya, Treating HHV-6 infections, the laboratory efficacy and clinical use of anti-HHV-6 agents, in Human Herpes Viruses HHV-6A, HHV-6B, and HHV-7. Diagnosis and Clinical Management, 3rd edn., ed. by L. Flamand, I. Lautenschlager, G. Krueger, D. Ablashi (Elsevier, Amsterdam, 2014), pp. 311–331. https://doi.org/10.1016/B978-0-444-62703-2.00019-7
G. Indrayanto, G.S. Putra, F. Suhud, Validation of in-vitro bioassay methods: application in herbal drug research. Profiles Drug Subst. Excip Relat. Methodol. 46, 273–307 (2021). https://doi.org/10.1016/bs.podrm.2020.07.005
O.A. Peña-Morán, M.L. Villarreal, L. Álvarez-Berber, A. Meneses-Acosta, V. Rodríguez-López, Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from Bursera fagaroides var. fagaroides on breast Cancer cell lines. Molecules. 21, 1013 (2016). https://doi.org/10.3390/molecules21081013
M. López-Lázaro, Editorial: how many times should we screen a chemical library to discover an anticancer drug? Drug Discov Today. 20, 167–169 (2015). https://doi.org/10.1016/j.drudis.2014.12.006
N. Weerapreeyakul, A. Nonpunya, S. Barusrux, T. Thitimetharoch, B. Sripanidkulchai, Evaluation of the anticancer potential of six herbs against a hepatoma cell line. Chin. Med. 7, 15 (2012). https://doi.org/10.1186/1749-8546-7-15
M. López-Lázaro, Two preclinical tests to evaluate anticancer activity and to help validate drug candidates for clinical trials. Onco Targets Ther. 2, 91–98 (2015). https://doi.org/10.18632/oncoscience.132
C. Pellerito, L. Nagy, L. Pellerito, A. Szorcsik, Biological activity studies on organotin(IV)n + complexes and parent compounds. J. Organomet. Chem. 691, 1733–1747 (2006). https://doi.org/10.1016/j.jorganchem.2005.12.025
Acknowledgements
The authors would like to thank to Higher Education Technology and Innovationa (HETI) Universitas Lampung, Republic of Indonesia for giving the funding for this project to be undertaken. Thank also goes to Dr. Huy Hoang of Institute of Molecular Biosciences (IMB) University of Queensland for NMR experimentation.
Funding
This work was funded by Higher Education Technology and Innovationa (HETI) Universitas Lampung, Republic of Indonesia for giving the funding for this project to be undertaken through Domestic Innovation Research and Collaboration 2023/2024 with contract number of 10629/UN26/HK.01.00/2023, 17 October 2023.
Author information
Authors and Affiliations
Contributions
SH, EKW, HW and SS: the primary responsibility for the design of the work. SS, DAST, MDF, KNB and TS: substantial contributions to the work and analysis. SH, EKW and HW: contributed to the interpretation of the data. SH and HW: drafting and revising the work critically for important intellectual content. All authors read and approved the fnal manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical Approval
Not applicable.
Informed Consent
Not applicable.
Consent for Publication
Not applicable.
Additional information
This paper is dedicated in memory of the late Dr. Charles E. Carraher, Jr. for his invaluable dedication as pioneer in the field of inorganic and organometallic polymers.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hadi, S., Winarno, E.K., Winarno, H. et al. Synthesis, Characterization and Antiproliferative Activity Test of Some Diphenyltin(IV) Hydroxybenzoates Against A549, MCF-7 and HeLa Human Cancer Cell Lines. J Inorg Organomet Polym (2024). https://doi.org/10.1007/s10904-024-03042-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10904-024-03042-2